The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer.
Simone Kayser
No relevant relationships to disclose
Cristina Boß
No relevant relationships to disclose
Michael Schumm
No relevant relationships to disclose
Judith Feucht
No relevant relationships to disclose
Stefan Stevanovic
No relevant relationships to disclose
Peter Lang
No relevant relationships to disclose
Rupert Handgretinger
No relevant relationships to disclose
Claus Garbe
No relevant relationships to disclose
Martin Röcken
No relevant relationships to disclose
Tobias Feuchtinger
Research Funding - Millennium